On one hand, cancer induces sarcopenia through mechanisms such as systemic inflammation, metabolic dysregulation, elevated catabolic cytokines (e.g., IL-6, TNF-α), and the direct myotoxic effects of chemotherapy and radiotherapy. This evidence concerns the gene IL6 and sarcopenia.